In turn, inhibition of the TWEAK-Fn14 axis by either genetic ablation of its receptor Fn14 or treatment of mice with anti-TWEAK antibodies improved left ventricular dysfunction after MI. The gene discussed is TNFRSF12A; the disease is myocardial infarction.